RealSeq Biosciences, a Santa Cruz biotech firm, recently secured additional funding to advance their revolutionary RNA diagnostics, aiming to transform early disease detection and patient care with their Ribomarker® platform.
Read MoreWe don’t only report the news, we make the news. Our news highlights and archive here.
Interested in getting 24,000+ eyeballs to view your company’s content? Become a Santa Cruz Works Partner or, see 3rd party content Sponsors.
RealSeq Biosciences, a Santa Cruz biotech firm, recently secured additional funding to advance their revolutionary RNA diagnostics, aiming to transform early disease detection and patient care with their Ribomarker® platform.
Read More